Publications
5808 Results
- Journal / Conference
- Invest New Drugs 6:223-226
- Year
- 1988
- Research Committee(s)
- Sarcoma
- Study Number(s)
- SWOG-8418
A phase II evaluation of cisplatin in unresectable diffusemalignant mesothelioma: A Southwest Oncology Group study.
- Journal / Conference
- Ann Intern Med 108:518-523
- Year
- 1988
- Research Committee(s)
- Genitourinary
A phase II clinical trial of interleukin-2 and lymphokineactivated killer cells in metastatic renal cancer.
- Journal / Conference
- ASCO 7:86(#331)
- Year
- 1988
- Research Committee(s)
- Brain
- Study Number(s)
- SWOG-7983
Low grade glioma: a randomized trial of radiotherapy versusradiotherapy plus CCNU: A SWOG study.
- Journal / Conference
- ASCO 7:247(#955)
- Year
- 1988
- Research Committee(s)
- Melanoma
- Study Number(s)
- SWOG-8049
A randomized phase III trial of high dose vitamin A versusplacebo for stage I malignant melanoma.
- Journal / Conference
- ASCO 7:178(#689)
- Year
- 1988
- Research Committee(s)
- Leukemia
- Study Number(s)
- SWOG-8124/25/26
Prognostic factor analysis of the outcome of marrowtransplantation or further chemotherapy for acute nonlymphocyticleukemia.
- Journal / Conference
- ASCO 7:133(#516)
- Year
- 1988
- Research Committee(s)
- Genitourinary
- Study Number(s)
- SWOG-8231
Phase II trial of alternating combination chemotherapy inpatients with extragonadal germ cell tumors: Southwest Oncology Groupstudy (SWOG 8231).
- Journal / Conference
- ASCO 7:119(#460)
- Year
- 1988
- Research Committee(s)
- Genitourinary
- Study Number(s)
- SWOG-8494 (INT-0036)
Treatment of newly diagnosed stage D2 prostate cancer withleuprolide and flutamide or leuprolide alone, phase III, intergroupstudy 0036.
- Journal / Conference
- ASCO 7:254(#985)
- Year
- 1988
- Research Committee(s)
- Melanoma
- Study Number(s)
- SWOG-8562
High dose cisplatin in metastatic melanoma: Comparison of two schedules.
- Journal / Conference
- ASCO 7:18(#69)
- Year
- 1988
- Research Committee(s)
- Breast
- Study Number(s)
- SWOG-8571
Non-alkylator induction and high-dose cyclophosphamide (CTX)consolidation in poor-risk, disseminated breast cancer. A SouthwestOncology Group (SWOG) study.
- Journal / Conference
- ASCO 7:195(#751)
- Year
- 1988
- Research Committee(s)
- Lung
- Study Number(s)
- SWOG-8606